What is the recommended treatment regimen for mild to moderate Alzheimer's disease using Aricept (donepezil)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Aricept (Donepezil) Treatment Regimen for Mild to Moderate Alzheimer's Disease

Initial Dosing

Start donepezil at 5 mg once daily in the evening, just prior to retiring, for patients with mild to moderate Alzheimer's disease. 1, 2, 3

  • The FDA-approved starting dose is 5 mg once daily for mild to moderate disease 3
  • Evening administration is specifically recommended to minimize sleep disturbances that can occur with morning dosing 1
  • This initial dose allows assessment of tolerability before escalation 2

Dose Escalation

Increase to 10 mg once daily after 4-6 weeks if the initial dose is well tolerated. 1, 2

  • The American Academy of Family Physicians recommends waiting 4-6 weeks before dose escalation 1
  • Some protocols suggest a minimum of 4 weeks at the lower dose 2
  • The 10 mg dose provides additional cognitive and functional benefits over 5 mg 2, 4
  • Gradual titration significantly improves tolerability and minimizes gastrointestinal side effects 1, 2

Expected Clinical Benefits

Donepezil produces statistically significant but modest improvements in cognition and global function, though these do not typically reach the 4-point change in ADAS-cog considered clinically significant. 2, 4

  • High-quality evidence demonstrates consistent treatment effects across all severity levels of Alzheimer's disease except mild cognitive impairment 2
  • Benefits on cognitive function, activities of daily living, and behavior can be maintained for approximately 21 to 81 weeks with donepezil 10 mg/day 2, 5
  • In clinical trials, the mean drug-placebo differences were 2.5-3.1 units on ADAS-cog and 0.3-0.4 units on CIBIC-plus 4
  • Beneficial effects on cognition are typically observed from week 3 of treatment 5

Side Effect Management

Monitor closely for dose-dependent gastrointestinal side effects, particularly during the first few weeks after initiation or dose increase. 1, 2

  • The relative risk of nausea/vomiting at 10 mg vs 5 mg is 2.54 1, 2
  • The relative risk of diarrhea at 10 mg vs 5 mg is 2.57 1, 2
  • The relative risk of anorexia at 10 mg vs 5 mg is 3.21 1, 2
  • These effects can be minimized by taking donepezil with food and using gradual titration 1
  • Initial increase in agitation may occur but typically subsides after the first few weeks 2

Critical Pitfalls to Avoid

Do not prescribe donepezil for mild cognitive impairment, as evidence shows no significant benefit in this population. 2

  • Avoid starting at high doses without gradual titration, as this significantly increases gastrointestinal side effects 2
  • Do not administer donepezil in the morning rather than evening, as this increases the risk of sleep disturbances 1, 2
  • Avoid setting unrealistic expectations for dramatic clinical improvement, as effects are statistically significant but modest in magnitude 2
  • Monitor for bradycardia or heart block, as cholinesterase inhibitors may have vagotonic effects on cardiac conduction 3
  • Observe patients closely for gastrointestinal bleeding, especially those at increased risk for developing ulcers 3

References

Guideline

Donepezil Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initiation and Management of Donepezil and Memantine for Dementia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.